Abstract:Sleep apnea involves almost one billion individuals throughout the world, including 40 million Americans. Of major medical concern is the fact that the prevalence of sleep apnea is significantly increasing due to the epidemic of obesity, physical inactivity, and diabetes mellitus which are important risk factors for the development and persistence of sleep apnea in individuals. Sleep apnea is characterized by multiple episodes of apnea or hypopnea during sleep, which cause nocturnal arousals, gasping for breath during the night, daytime sleepiness, irritability, forgetfulness, fatigue and recurrent headaches. Obstructive sleep apnea occurs when upper airway obstruction occurs in an individual during sleep with absent or markedly reduced airflow in the presence of continued activity of inspiratory thoracic and diaphragmatic muscles. Central sleep apnea is defined as the absence or the significant reduction of naso-oral airflow due to the withdrawal during sleep of ponto-medullary respiratory center stimulation of the nerves of the inspiratory thoracic and diaphragmatic muscles and absence of contraction of these muscles during apnea. Complex sleep apnea occurs when an individual exhibits characteristics of both obstructive and central sleep apnea. The severity of sleep apnea is measured by polysomnography and the apnea hypopnea index (AHI), which is the average number of apneas and hypopneas per hour of sleep measured by polysomnography. Sleep apnea is mild if the AHI is 5-14/hour with no or mild symptoms, moderate if the AHI is 15 to 30/hour with occasional daytime sleepiness, and severe if the AHI is >30/hour with frequent daytime sleepiness that interferes with the normal activities of daily life. Chronic sleep apneas and hypopneas followed by compensatory hyperpneas are associated with significant adverse cardiovascular consequences including: 1) recurrent hypoxemia and hypercarbia; 2) Increased sympathetic nerve activity and decreased parasympathetic nerve activity; 3) oxidative stress and vascular endothelial dysfunction; and 4) cardiac remodeling and cardiovascular disease. Moderate or severe sleep apnea significantly increases the risk of coronary artery disease, congestive heart failure, cerebral vascular events (strokes), and cardiac dysrhythmias, and also increase the morbidity and mortality of these diseases. Nevertheless, sleep apnea is currently underdiagnosed and untreated in many individuals due to the challenges in the prediction and detection of sleep apnea and a lack of well-defined optimal treatment guidelines. Chronic continuous positive airway pressure for ≥4 hours/night for >70% of nights is beneficial in the treatment of patients with sleep apnea. CPAP Improves sleep quality, reduces the AHI, augments cardiac output and increases oxygen delivery to brain and heart, reduces resistant hypertension, decreases cardiac dysrhythmias, and reduces daytime sleepiness. The present article discusses the diagnosis of obstructive sleep apnea, central sleep apnea, and complex apnea. Thereafter the important pathophysiologic mechanisms in sleep apnea and the relationship of these pathophysiologic mechanics to atherosclerotic vascular disease are reviewed. Guidelines are then provided for the treatment of mild, moderate and severe sleep apnea In order to reduce the cardiovascular morbidity and mortality caused by sleep apnea and facilitate the diagnosis and the long-term, effective treatment of sleep apnea in patients, the close cooperation is necessary of cardiovascular specialists, pulmonary specialists, and respiratory therapy/ rehabilitation specialists.

Dilated Cardiomyopathy As the First Presentation of Sleep Apnoea/Hypopnoea Syndrome: A Case Report and Review of Literature

Effect of Continuous Positive Airway Pressure Ventilation on Nocturnal ST-segment Changes in Patients with Sleep-Disordered Breathing

Integrating machine learning approach to identify sleep-disordered breathing in hypertrophic cardiomyopathy

Implication of Polysomnography in Portable Monitor for Detecting Sleep Apnea in Patients With Congestive Heart Failure in Remote Area

SLEEP APNEA IS A COMMON AND DANGEROUS CARDIOVASCULAR RISK FACTOR

Clinical analysis of 45 cases of obstructive sleep apnea-hypopnea syndrome who were first diagnosed coronary heart disease

[Clinical features of respiratory failure and heart failure in patients with sleep disordered breathing]

Advances in Multimodal Echocardiographic Evaluation of Ischemic Cardiomyopathy due to Obstructive Sleep Apnea Syndrome

Obstructive Sleep Apnea-Hypopnea and Cardiovascular Diseases in Adults

Validation of the Advanced Event Detection in Patients with Sleep Apnea Hypopnea Syndrome Using Auto-Cpap Treatment

Study of Echocardiography Changes in Patients with Obstructive Sleep Apnea Syndrome

[A case of severe obstructive sleep apnea hypopnea syndrome with urinary and anal incontinence].

Role of Obstructive Sleep Apnea Hypopnea Syndrome in Cardiovascular Disease

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

The importance of sleep-disordered breathing in cardiovascular disease

[Value of Actigraphy and Oximetry for Diagnosing Sleep Apnea-Hypopnea Syndrome].

Progresses in Clinical and Basic Research of Myocardial Injury Caused by Obstructive Sleep Apnea

Analysis of right ventricular systolic function in patients with obstructive sleep apnea hypopnea syndrome complicated with COPD

Relationship of Cardiac Autonomic Nervous Dysfunction and Cardiac Arrhythmia in Patients with Obstructive Sleep Apnea Syndromes

Continuous Positive Airway Pressure Treatment for Functional Cardiac Arrhythmias Combined with Obstructive Sleep Apnea Hypopnea Syndrome